等待开盘 08-21 09:30:00 美东时间
+2.480
+0.76%
Lending support to his choice, BTIG analyst initiated coverage on Rocket Companies with a Buy rating and $25 price target. Cisco and Insulet also discussed.
08-20 20:23
Insulet (NASDAQ:PODD) has outperformed the market over the past 15 years by 10....
08-18 22:45
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $330 to $350.
08-08 23:08
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on T...
08-07 23:08
Makers of insulin delivery systems, Tandem Diabetes Care (NASDAQ:TNDM) and Insulet (NASDAQ:PODD), marked a contrasting stock performance on Thursday as Wall Street reacted to their Q2 2025 results, wh...
08-07 22:04
Insulet (NASDAQ:PODD) lowers FY2025 sales outlook from $2.49 billion-$2.55 billion to $2.45 billion-$2.52 billion vs $2.53 billion estimate.
08-07 19:25
Insulet (NASDAQ:PODD) sees Q3 sales of $663.558 million-$679.875 million vs $645.86 million analyst estimate.
08-07 19:16
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Insulet (NASDAQ:PODD) has outperformed the market over the past 10 years by 12....
08-02 04:45